DNA.WS
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
DNA.WS
Delisted
DNA.WS was delisted on the 3rd of September, 2024.
40 hedge funds and large institutions have $2.73M invested in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 7 closing their positions.
Holders
40
Holders Change
-4
Holders Change %
-9.09%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
7
Closed
7
Calls
$89K
Puts
–
Net Calls
+$89K
Net Calls Change
-$182K
Top Buyers
| 1 |
LP
1
LMR Partners
London,
United Kingdom
|
$1.64M |
| 2 |
2
Walleye Capital
New York
|
$95.5K |
| 3 |
SS
3
Simplicity Solutions
Minneapolis,
Minnesota
|
$28.7K |
| 4 |
VF
4
Virtu Financial
New York
|
$4K |
| 5 |
GC
5
Guggenheim Capital
Chicago,
Illinois
|
$71.9K |
